1. Introduction {#sec0005}
===============

Porcine epidemic diarrhea virus (PEDV) is an enveloped, single-stranded, positive-sense RNA virus that belongs to the order *Nidovirales*, family *Coronaviridae* and genus *Alphacoronavirus*. The genome of PEDV is approximately 28 kb in length and is composed of seven open reading frames (ORFs) ([@bib0285]). The 5′ two thirds of the genome contains two overlapping ORFs, ORF1a and ORF1b, which encode nonstructural proteins that direct genome replication, transcription and viral polyprotein processing. The remaining PEDV genome contains five ORFs encoding four structural and an accessory protein in the following order: spike (S), ORF3, envelope (E), membrane (M) and nucleocapsid (N) proteins ([@bib0135]).

PEDV is highly contagious. Fecal-oral transmission is the major route for the spread of PEDV in swine. Contaminated feed and feed ingredients may serve as vehicles for PEDV transmission to naïve pigs ([@bib0125], [@bib0130], [@bib0430]). In addition, evidence of PEDV aerosol transmission has been reported ([@bib0010]). During disease outbreaks, vomiting, watery diarrhea, dehydration and growth retardation are observed. High mortality occurs in young piglets exposed to the virulent PEDV strains. Microscopic examination of infected nursing pigs revealed atrophic enteritis ([@bib0120], [@bib0225], [@bib0550]). Clinical signs and histopathologic features of PEDV infection resemble that of transmissible gastroenteritis virus (TGEV) infection, which is also an alphacoronavirus ([@bib0465], [@bib0480]). Differential diagnosis of these two viruses relies mainly on molecular ([@bib0265], [@bib0400]) and serological assays ([@bib0155], [@bib0520]).

At the end of 2010, pandemic porcine epidemic diarrhea (PED) outbreaks occurred in China and caused large economic losses. Subsequently, starting in the spring of 2013, the pork industry in the United States (US) was also severely affected by this disease. A lack of protective lactogenic immunity in the US swine population ([@bib0550]) and PEDV antigenic variations between the traditional attenuated vaccine and current highly virulent PEDV field strains in Asia ([@bib0320], [@bib0325]) were major contributors to severe PED outbreaks. Therefore, the development of updated PEDV vaccines is urgently needed.

In this article, genetic, antigenic and pathogenic features of global PEDV strains are reviewed. Throughout this review, the terms "classical" and "emerging" PEDV strains correspond to the PEDV prototype CV777-like strains that have appeared since the 1970s and those PEDV strains detected globally after 2010, respectively. Also, emerging PEDV strains are divided into two major groups based on features of the S gene and their virulence in young pigs: (1) "non-S INDEL (insertions and deletions)", which is "highly virulent" and causes pandemic PED outbreaks worldwide; and (2) "S INDEL" strains that are less pathogenic in terms of lower mortality. This nomenclature is proposed based on sequence analysis as explained in detail in Section [2](#sec0010){ref-type="sec"}.

2. Evolution of global PEDV strains {#sec0010}
===================================

2.1. Historic/classical PEDV strains emerged in the 1970s and were discovered in Europe and Asia {#sec0015}
------------------------------------------------------------------------------------------------

The first reported PED outbreak occurred in swine populations in 1971 in the United Kingdom ([@bib0040]), but no PEDV was isolated from this outbreak. In 1978, PEDV CV777 strain was confirmed as the cause of PED by the experimental inoculation of pigs with the virus from an outbreak that occurred in 1977 in Belgium ([@bib0440]). The complete genomic sequence of the prototype PEDV CV777 strain was characterized later by [@bib0285]. During the 1970s and 1980s, PEDV was widespread in European countries and caused epidemics with severe losses in suckling pigs ([@bib0480]). Thereafter PEDV did not persist in Europe except in isolated outbreaks. As a result, no vaccine was developed and used in Europe. Before 2010, PED had been reported in multiple European countries (the United Kingdom, Belgium, The Czech Republic, Hungary, France, Switzerland, Germany, and Italy) ([@bib0520]).

In Asia, PEDV has been reported in Shanghai, China since 1973 ([@bib0575]). However, not until 1984 were the causative agents, PEDV H, CH and J strains, especially the J strain, isolated in primary fetal pig intestinal cell cultures and confirmed to be PEDV by immunofluorescence assay (IFA), two-way cross virus neutralization (VN), and in vivo pig cross-protection assays comparing tissue culture-adapted (TC) PEDV and TGEV, and their respective antisera ([@bib0660]). However, the sequence information for the early PEDV strains (H, CH, and J) is unavailable (personal communication with Drs. Li Feng and Jianfei Chen, Division of Swine Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China, and Dr. Dongbo Sun at the College of Animal Science and Veterinary Medicine, at Heilongjiang Bayi Agricultural University, Daqing, China). Since 1994, inactivated or live attenuated PEDV CV777 strain vaccines have been developed ([@bib0575]). The inactivated, bivalent TGEV and PEDV vaccine (1999 to present) and the attenuated, bivalent TGEV and PEDV vaccine (2003--2006) have been used extensively in the Chinese pig population, and they have played an important role in the control of PEDV infections in China. Before October 2010, PEDV infections were endemic in Chinese pig populations, but there were no reports of large-scale outbreaks ([@bib0575]).

PEDV was first reported in South Korea in 1992 ([@bib0425]). From 2004--2013, PED outbreaks were well controlled by oral vaccination with a cell culture-attenuated DR13 strain vaccine ([@bib0420], [@bib0520]). In Japan, PEDV outbreaks were reported from the early 1980s ([@bib0540]) and temporarily disappeared in 2006, probably due to the use of an attenuated PEDV 83P-5 (or P-5V) strain vaccine (Nisseiken Co. Ltd., Japan) since 1997 ([@bib0375], [@bib0490], [@bib0540], [@bib0520]). Similar classical PEDV strains also spread to and caused PED outbreaks in Vietnam, Thailand, Taiwan, and the Philippines. Since 2011, the attenuated PEDV DR13 vaccine also has been used in the Philippines ([@bib0520]).

No PED cases were reported in the American, African and Australian continents prior to 2013. We will refer to these historic PEDV strains as classical strains because such viruses are still detected in the field, such as CHN/SD-M/2012 and THA/EAS1/2014, to differentiate them from the emerging strains detected worldwide after 2010.

2.2. Since 2010, highly virulent PEDV strains emerged in China and subsequently spread to other Asian countries, the Americas, and back into Europe {#sec0020}
---------------------------------------------------------------------------------------------------------------------------------------------------

Starting from October 2010, severe PEDV outbreaks occurred in the Chinese pig population and caused enormous economic losses ([@bib0575], [@bib0565]). Although PEDV vaccines based on classical PEDV strain CV777 were widely used in China, the mortality in neonatal piglets was high, reaching 50--100%, indicating the emergence of highly virulent PEDV variants.

In April, 2013, the first highly virulent PEDV infections emerged in swine farms in the US ([@bib0550]). By March 12, 2015, PEDV had spread to 36 US states, including the geographically separated state of Hawaii, and one US territory, Puerto Rico ([https://www.aasv.org/Resources/PEDv/PEDvWhatsNew.php](http://https://www.aasv.org/Resources/PEDv/PEDvWhatsNew.php){#intr0010}). In the first year, PEDV killed about 10% of the US swine population, accounting for deaths of 7 million pigs, and resulting in major economic losses to the US swine industry (<http://www.dailykos.com/story/2014/4/27/1295143/-PEDv-virus-has-killed-10-of-U-S-pig-population-causing-spike-in-prices>). The last large-scale outbreak in the US ended in the spring of 2014 ([@bib0210]). By 2014, the highly virulent PEDV had spread to other countries in the Americas, including Canada, Mexico, and Columbia ([@bib0630]).

In October 2013, the highly virulent PEDV emerged in Japan, and about 1000 outbreaks were reported by 2015 ([@bib0375]). In South Korea and Vietnam, the highly virulent PEDV emerged in 2013, based on complete genomic sequences ([@bib0270], [@bib0635]). In Thailand, both classical and highly virulent PEDV strains were sequenced recently ([@bib0075]). PEDV outbreaks emerged in Taiwan in late 2013 ([@bib0315]) and in Philippines in 2014 ([@bib0275]). However, no complete genomic sequence data are available for these strains. The year 2013 was critical for the spread of the highly virulent PEDV strains to other swine producing countries besides China. However, except for the Ukraine ([@bib0105]), no highly virulent PEDV infections were reported in the European, African and Australian continents.

2.3. The S INDEL PEDV strains emerged in June 2013 in the US and have since been detected in Asia and Europe {#sec0025}
------------------------------------------------------------------------------------------------------------

A PEDV variant OH851 strain, designated as S INDEL PEDV, was first discovered in Ohio, USA ([@bib0645]). Later, it was found that S INDEL strains, such as Indiana12.83/2013 and Minnesota52 strains, existed in samples collected in the US in June 2013, just 1--2 months later than the emergence of the highly virulent PEDV strains in this country ([@bib0630]). The N-terminal region of the S protein of these strains has an amino acid insertion (aa 161--162) and two deletions (aa 59--62, and aa 140) compared with those of the highly virulent PEDV strains, but similar to that of the classical PEDV strains (Fig. S9) ([@bib0400]). Although the amino acid sequences of the S proteins of S INDEL strains are closer to the classical strains than to the highly virulent US strains ([Fig. 2](#fig0010){ref-type="fig"} ), the rest of the genes (ORF1, ORF3, E, M and N) of S INDEL strains group together with the emerging highly virulent PEDV strains from China, North American, etc. (Figs. S1, S4--S7) ([@bib0630]). Therefore, S INDEL strains fall into the emerging NA clade at the complete genomic sequence level ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Phylogenetic tree of the complete genomes of PEDV strains and closely related alphacoronaviruses. Classical and the emerging PEDV strains, a bat alphacoronavirus (in bold), the recombinant porcine enteric coronavirus between TGEV and PEDV (in brown), three TGEV strains and one PRCV strain were included to generate a Maximum Likelihood phylogenetic tree using General Time Reversible nucleotide substitution model and supported with a bootstrap test of 1000 replicates in MEGA 6.06 software ([@bib0590]). The number on each branch indicates the bootstrap value. The scale represents the nucleotide substitutions per site. Classical PEDV strains are in green. Emerging US, Chinese and European PEDV strains are in blue, red, and purple, respectively. Emerging S INDEL PEDV strains are labeled with a solid triangle in front of the strain name.Fig. 1Fig. 2Phylogenetic tree of the genomes of PEDV strains, excluding the UTRs. A Maximum Likelihood phylogenetic tree was constructed using General Time Reversible nucleotide substitution model and supported with a bootstrap test of 1000 replicates in MEGA 6.06 software ([@bib0590]). The number on each branch indicates the bootstrap value. The scale represents the nucleotide substitutions per site. Each PEDV strain is indicated in the following format: Country origin (three letter code: BEL, Belgium; CAN, Canada; CHN, China; COL, Columbia; FRA, France; GER, Germany; JPN, Japan; KOR, Korea; MEX, Mexico; SVN, Slovenia; THA, Thailand; UKR, Ukraine; USA, the United States; VNM, Vietnam)/strain name/year of sample collection (Genbank accession number) followed by passage (P) number for tissue culture-adapted strains. Classical PEDV strains are in green. Emerging US, Chinese and European PEDV strains are in blue, red, and purple, respectively. Emerging S INDEL PEDV strains are labeled with a solid triangle in front of the strain name.Fig. 2

In December 2013, an S INDEL PEDV MYZ-1/JPN/2013 strain was identified in Japan ([@bib0585]). Since 2014, PEDV strains from Canada, Korea, Belgium, France, Germany, Portugal, Slovenia and Netherlands have been described, and these strains cluster with the US S INDEL strains ([@bib0170], [@bib0175], [@bib0275], [@bib0295], [@bib0385]).

2.4. Other variant PEDV strains {#sec0030}
-------------------------------

### 2.4.1. PEDV variants that have deletions in the S protein {#sec0035}

The S protein of coronaviruses is responsible for binding to cellular receptors to initiate infection and it induces neutralizing antibodies in vivo ([@bib0300]). Mutations, especially deletions and/or insertions in the S protein may change the pathogenicity and tissue tropism of coronaviruses. For TGEV, a large deletion (621--681 nt) in the N-terminus of S gene reduced its virulence and changed its tissue tropism from intestinal to respiratory \[subsequently designated porcine respiratory coronavirus (PRCV)\] ([@bib0480]). For PEDV, Korean strain MF3809/2008 was identified with a large deletion (204 aa) at amino acid positions 713--916 of the S protein ([@bib0425]). Except for this large deletion, its S protein was similar to that of highly virulent PEDV strains ([Fig. 3](#fig0015){ref-type="fig"} ). Later, a minor PEDV variant (USA/Minnesota188/2014) with a 2 aa-deletion in the S protein was reported as very virulent ([@bib0365]). In China, a field CHN/FL2013 strain with a 7 aa-earlier termination of S protein, like the classical CHN/LZC strain, was also reported ([@bib0675]). Laboratory pig experiments showed that the virulence of FL2013 was reduced. A field PEDV strain JPN/Tottori2/2014 with a 194 aa-deletion in the position aa 23--216 of the S protein was discovered ([@bib0395]). Interestingly, a single US PEDV strain, PC177, with a 197 aa-deletion in a similar position (aa 34--230) of the S protein, was isolated from Vero cell culture ([@bib0400]). Later, it was confirmed that the large deletion originated during cell culture adaptation because the wild-type (WT) PC177 strain in the original field piglet intestinal contents was successfully sequenced and did not have the large deletion in the S protein (GenBank accession no. KR078300). The pathogenicity of these PEDV variants is discussed in Section [4](#sec0105){ref-type="sec"} in detail.Fig. 3Phylogenetic tree of the S proteins of PEDV strains. A Maximum Likelihood phylogenetic tree was constructed using Jones-Taylor-Thornton (JTT) model and supported with a bootstrap test of 1000 replicates in MEGA 6.06 software ([@bib0590]). The number on each branch indicates the bootstrap value. The scale represents the nucleotide substitutions per site. Each PEDV strain is indicated in the following format: Country or area origin (three letter code: BEL, Belgium; CAN, Canada; CHN, China; COL, Columbia; FRA, France; GER, Germany; JPN, Japan; KOR, Korea; MEX, Mexico; PHI, Philippine; SVN, Slovenia; THA, Thailand; TWN, Taiwan; UKR, Ukraine; USA, the United States; VNM, Vietnam)/strain name/year of sample collection (Genbank accession number) followed by passage (P) number for tissue culture-adapted strains. Classical PEDV strains are in green. Emerging US, Chinese and European PEDV strains are in blue, red, and purple, respectively. Emerging S INDEL PEDV strains are labeled with a solid triangle in front of the strain name. The recombinant porcine enteric coronavirus between TGEV and PEDV is in brown.Fig. 3

### 2.4.2. PEDV variants that have deletions in the ORF1a region {#sec0040}

Most recently, a highly virulent PEDV strain, HUA-14PED96/2014, was detected from a piglet with severe diarrhea in Vietnam. It contains a 72 nt-deletion in the open reading frame 1a (ORF1a), corresponding to a 24 aa-DEL in the nsp3 protein, and is grouped with the Chinese highly virulent PEDV cluster ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0090]).

### 2.4.3. Recombinant PEDV strains {#sec0045}

Recombination occurs frequently among PEDV strains and was detected in seven main areas of the PEDV genome excluding the 5′- and 3′-UTRs: nsp2, nsp3, nsp14-16, S1 domain, and N gene ([@bib0210]). For example, S INDEL strains USA/Iowa106/2013 and USA/Iowa107/2013 (Genbank accession no. [KJ645696](ncbi-n:KJ645696){#intr0020}; 1 nt different from Iowa106 strain at the genomic level) were probably the result of several recombination events: the ORF 1a and 1b region was most similar to that of the highly virulent strains CHN/AH2012 and CHN/ZMDZY/2011, respectively; the S1 and S2 region of the S protein was most similar to that of the classical strain CHN/CH/S/1986 and the highly virulent ZMDZY/2011 strain, respectively; and the 3′ end (E, M, and, N genes) was dissimilar to that of either AH2012 or ZMZDY/2011 strains ([@bib0630]). USA/Minnesota211/2014 strain is a recombinant between a highly virulent strain (genomic fragment from the middle of nsp2 to the middle of nsp14) and an S INDEL strain ([@bib0210]). Most recently, the CH/HNQX-3/14 strain was reported as a recombinant among the classical strains CV777 and DR13, and the highly virulent CHN/ZMDZY/11 strain. It grouped together with the CH/ZMDZY/11 strain at the genomic level ([@bib0310]). Not surprisingly, this strain was detected from a swine farm that is located in the same province as the CHN/ZMDZY/11 strain, and both CV777 and DR13 PEDV vaccines were used at the farm.

### 2.4.4. Recombinant enteric coronavirus {#sec0050}

Although both PEDV and TGEV belong to the *Alphacoronavirus* genus and cause indistinguishable enteritis ([@bib0480]), no recombinant virus between TGEV and PEDV had been found until recently ([@bib0025]). This recombinant porcine enteric coronavirus, Italy/213306/2009 strain, has potential parental strains TGEV H16 strain (major, backbone) and classical PEDV CV777 strain (minor, S gene) ([Fig. 1](#fig0005){ref-type="fig"}). This virus was circulating in 2009--2012 in Italy. Another TGEV/PEDV chimeric virus (SeCoV/GER/L00930/2012), sharing similar recombination pattern and 99.5% nucleotide identity with the Italy/213306/2009 strain, was reported in Germany ([@bib0005]). It is important to determine the virulence and tissue tropism of these chimeric viruses and to monitor how they evolve in the swine population.

2.5. Evolution of global PEDV strains {#sec0055}
-------------------------------------

### 2.5.1. Sequence analysis suggests the potential origin of emerging PEDV strains {#sec0060}

Phylogenic analysis of the full-length genomes and the genome organization showed that all PEDV strains are most closely related to bat alphacoronaviruses within the *Alphacoronavirus* genus ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0205], [@bib0595], [@bib0630]), suggesting that PEDV strains probably originally evolved from bat alphacoronaviruses and were transmitted cross-species directly or indirectly to pigs. There were about 300 complete genomes of PEDV listed in the GenBank database (<http://www.ncbi.nlm.nih.gov/>) at the beginning of 2016. For phylogenetic analysis of PEDV strains, we selected around 100 representative strains from published papers based on the following criteria: (1) strains collected in different geographical areas; (2) strains whose pathogenesis have been studied; (3) vaccine strains and strains whose antigenicity will be discussed in this review; and 4) both TC and wild type (WT) strains. The WT genomes of two PEDV strains (PC21A-WT and PC177-WT), whose TC sequences have been reported previously ([@bib0400]), were successfully sequenced and included in this analysis. Sequence alignment was performed using ClustalW method. Maximum Likelihood phylogenetic trees were constructed using General Time Reversible nucleotide substitution model (for nucleotide sequences) or Jones-Taylor-Thornton (JTT) model (for amino acid sequences) and supported with a bootstrap test of 1000 replicates in MEGA 6.06 software ([@bib0590]).

Based on the nearly complete genomes, excluding the UTRs due to the lack of these regions for many PEDV strains, all PEDV strains separated into two distinct groups: "classical" and "emerging" PEDV strains ([Fig. 2](#fig0010){ref-type="fig"}). Phylogenetic trees based on ORF1 and M also confirmed the two distinct groups (Figs. S1 and S6). The nucleotide percent identity of the PEDV genomes between "classical" and "emerging" clusters is 96--98%. Since PEDV has a relatively low mutation rate (6.2 × 10^−4^ substitutions/site/year) similar to TGEV and other animal coronaviruses ([@bib0210]), it seems likely that the PEDV strains have diverged due to host adaptation. On the other hand, evidence supporting a different origin of the two distinct clusters of PEDV strains exists. [@bib0205] found that in the 5′-proximal region of the 5′-UTR, all the emerging highly virulent PEDV strains share a unique insertion \[a T at nt 48, the loop of stem-loop (SL) 2 structure\] and two deletions (an A deletion between nt 72 and 73, immediately after the core sequence of the leader transcription-regulating sequence; a 4 nt (TTCC)-deletion in SL4) with the bat coronavirus (BtCoV)/512/2005 strain compared with the PEDV prototype CV777 strain. Sequence alignments of the 5′-UTR of classical and emerging PEDV strains showed that all emerging PEDV strains and some classical strains, such as Korean DR13/1999 and Chinese CH/S/1986, contain the same insertion and deletions (Fig. S8). One classical strain SM98/2010 does not have the insertion T at nt 48, but has the two deletions compared with CV777 strain. How such a unique feature was obtained by these PEDV strains is still unknown. If the changes result in a replication advantage for PEDV strains, the genetic changes may evolve and be selected. However, the process for acquiring the individual insertion and deletions in PEDV, or intermediate PEDV strains, has not been determined. It is also possible that PEDV strains obtained this region from a BtCoV/512/2005-like coronavirus directly by recombination.

Although complete genomic sequences are lacking for many PEDV strains, information from the S protein may highlight when the emerging non-S INDEL strains evolved since the S genes are available for some samples collected before 2010, and the emerging non-S INDEL and classical groups can be clearly differentiated in an S protein tree ([@bib0580]) ([Fig. 3](#fig0015){ref-type="fig"}). It appears that the non-S INDEL strains, such as KOR/Chinju99/1999 strain, had emerged before 2010. An earlier report also indicated the emergence of new PEDV strains since early 2006 in PEDV immunized swine herds in China ([@bib0050]). Unfortunately, only the ORF3 gene was analyzed in this study. To date, when, where and how the original emerging non-S INDEL PEDV strains evolved is still unknown. Recently, [@bib0245] reported that the highly virulent PEDV grew in duck intestinal epithelial cells, raising the question of whether there are other reservoirs besides bats for PEDV. All those questions need to be investigated further.

### 2.5.2. Complex evolution of emerging PEDV strains {#sec0065}

We divide the emerging PEDV strains into "S-INDEL" and "non-S INDEL" (or "highly virulent") because the former and later cause mild and severe PED, respectively, in the field and in laboratory pig experiments (see Section [4](#sec0105){ref-type="sec"} for detail). In the complete genomic tree of PEDV strains ([Fig. 2](#fig0010){ref-type="fig"}), non-S INDEL PEDV strains from China are more closely related to each other than to the strains from the US and European countries, except for CHN/AH2012 that is closer to the US strains (with nt identity of 99.33--99.61%) than to the Chinese strains (with nt identity of 98.10--99.50%). Because there are no cut-off values for genogrouping or genotyping for PEDV strains, we tentatively refer to them as emerging Asian Clade and emerging North American (NA) Clade. Phylogenetic analysis of ORF1 supports such a grouping system (Fig. S1). For the phylogenetic trees based on ORF3, E, M or N genes (Figs. S4--S7), NA non-S INDEL, S INDEL, and some Chinese emerging strains are clustered together. Therefore, those regions are probably not immediate targets in the recent evolution of emerging PEDV strains and there is a lack of enough information to generate evolution inference.

Other researchers also found such inconsistencies when phylogenic analyses were conducted using complete genomic sequences or different regions of the genome ([@bib0055], [@bib0275], [@bib0535], [@bib0580], [@bib0615], [@bib0630]). It is probably due to recombination among PEDV strains, which is reported as a major evolution pattern for coronaviruses ([@bib0360]). Recombination analysis and analysis of single nucleotide polymorphisms (SNPs) provided additional information to trace the evolution of PEDV strains ([@bib0205], [@bib0210], [@bib0535], [@bib0615], [@bib0630]). Recently, a novel method using sequence motifs, which was defined as "a highly conserved region at the same position in the genome that was exclusively shared between several of the PEDV strains", was developed to study the relationship among emerging PEDV strains detected in 2013--2014 ([@bib0670]). So far, the results of these two analyses are in agreement. The NA non-S INDEL strains probably evolved from different Chinese emerging strains by recombination ([@bib0615], [@bib0630]). The non-S INDEL strains showed an overall high similarity to the highly virulent CHN/AH2012 strain across the genome except for the S1 region where they showed the highest similarity to another highly virulent CHN/ZMDZY/2011 strain. The S INDEL Iowa106 and Iowa107 strains probably resulted from multiple recombination events among the classical (CHN/CH/S-like strain for S1 region) and at least two different highly virulent strains (CHN/ZMDZY/2011-like strain for ORF1b and S2 regions, and CHN/AH2012-like strain for the remaining genome) ([@bib0630]). It is notable that the Ukraine, Japanese and Korean emerging non-S INDEL strains are within the NA non-S INDEL, but not the emerging Asian clade, suggesting global spread of the NA non-S INDEL strains ([Fig. 2](#fig0010){ref-type="fig"}). On the other hand, several PEDV strains from Vietnam and Thailand clustered together with the emerging Chinese strains.

Except for the Ukraine Poltava01/2014 strain, the emerging European strains clustered within the S INDEL clade, which contains strains from NA, Japan and Korea. Surprisingly, no S INDEL strains were reported from China where both the classical and the emerging PEDV strains are co-circulating. The S INDEL strains could be overlooked due to the following possibilities: (1) in general the S INDEL PEDV strains cause milder diarrhea in pigs compared to the highly virulent emerging strains, so clinical samples may not be collected for diagnosis; and (2) many diagnostic tests or surveillance studies did not differentiate S INDEL strains from classical (if the S1 region of the S gene is the target) or emerging non-S INDEL PEDV strains (if S2, ORF3, E, M or N region is the target), such as using real-time RT-PCR targeting the N gene or sequence analysis of the S1 region only ([@bib0400]). Interestingly, based on the genetic motif analysis ([@bib0670]), S INDEL strains GER/L00719/2014 and USA/Indiana12.83/2013 contain 6 of the 8 genetic motifs (M1-M6) along the genome. Japanese S INDEL strains (MYZ-1/2013, KCH-1/2014, and KCH-2/2014) contain 2 motifs (M3 and M6) that are different from any of the US S INDEL strains, whereas the JPN/OKY-1/2014 strain contains the same 2 motifs (M5 and M6) as the USA/Iowa23.57/2013 strain. South Korean S INDEL strain KNU-1406-1/2014 contains 3 genetic motifs, similar to the USA/OH851/2014 strain. These results suggest a close relatedness of these global S INDEL strains. However, the origin of emergence of these strains and the direction of transmission of S INDEL strains are unknown.

In summary, based on genetic analysis, the global PEDV strains are divided into two major groups: the classical PEDV strains that first emerged in 1970s in Europe and the highly virulent PEDV strains that emerged in 2010 in China (Fig. S10). Many questions remain unanswered, such as whether the later strains evolved directly from the former strains, and when the non-S INDEL and S INDEL emerging strains were introduced into the US and Europe. [@bib0210] reported that the separate evolution of Chinese and US strains (both non-S INDEL and S INDEL) is estimated to have begun around 2006--2009, several years earlier than 2013 when the current US PEDV strains emerged. As of March 2016, no PEDV strains have been reported from the African and Australian continents. Both classical (including attenuated vaccines) and emerging PEDV strains, and TGEV strains are circulating in Asian countries, including China, that accounts for half of global swine production. Because coronaviruses are RNA viruses and recombination occurs frequently, more PEDV variants are expected to emerge in the future. Further availability of more complete genome sequences, especially those from European and Asian strains, and from historical samples before 2010, and a more comprehensive analysis will improve our understanding of the origin, evolution, and diversity of global PEDV strains.

3. Serological cross-reactivity between PEDV and other coronaviruses and antigenic variations among different PEDV strains {#sec0070}
==========================================================================================================================

3.1. Antigenic relationships between PEDV and other alphacoronaviruses {#sec0075}
----------------------------------------------------------------------

Traditionally, coronaviruses were classified on the basis of antigenic cross-reactivity, and three distinct antigenic groups (1--3) were delineated ([@bib0470]). This antigenicity-based classification matched well with the results of phylogenetic analysis until the alphacoronavirus PEDV and human coronavirus 229E were identified ([@bib0485], [@bib0655]). Based on viral genome sequences, TGEV and PEDV were classified as two independent species belonging to the *Alphacoronavirus* genus. TGEV and other species members within the *Alphacoronavirus* genus, including porcine respiratory coronavirus (PRCV), feline infectious peritonitis virus (FIPV), and canine coronavirus, showed antigenic cross-reactivity in various immunoassays ([@bib0200], [@bib0485]). In contrast, most previous studies reported that PEDV and TGEV had distinct antigenic reactivity. Neither the prototype PEDV CV777 strain nor the other PEDV variants cross-reacted serologically with selected TGEV strains or other coronaviruses ([@bib0195], [@bib0445], [@bib0550]). However, exceptions were reported as described subsequently ([@bib0185], [@bib0325], [@bib0340], [@bib0685]).

Some reports showed a low degree of antigenic cross-reactivity between PEDV and other alphacoronaviruses. The antigens of PEDV CV777 strain in pig intestinal epithelial cells were detected by immunofluorescent staining with ascites collected from a cat that had succumbed to FIPV ([@bib0685]). Two-way antigenic cross-reactivities between PEDV and FIPV were also revealed by ELISA and Western blot at the N protein level ([@bib0685]). [@bib0185] reported that sera collected from a putative coronavirus-infected mink cross-reacted with both PEDV and TGEV N proteins, supporting the idea that these viruses were distinct species, but partially related antigenically. Recently, we demonstrated that four distinct PEDV strains (prototype CV777, highly virulent PC22A, S INDEL Iowa106 and S 197aa-del PC177) were all recognized by hyperimmune pig antisera to TGEV Miller in a cell culture immunofluorescence assay (CCIF) ([Table 1](#tbl0005){ref-type="table"} ) ([@bib0325]). The pig antisera to TGEV Miller demonstrated high homologous titer (10,640) against TGEV Miller, but lower heterologous titers (160--640) to PEDV CV777 and other US PEDV strains. In agreement with a previous study ([@bib0685]), assessment of a panel of TGEV monoclonal antibodies (MAbs) ([@bib0505], [@bib0510]) supported at least one conserved epitope on the TGEV N protein (located between aa 1--205, recognized by TGEV N MAb 14G9.3C) that contributed to this cross-reactivity. Sequence alignments showed two highly conserved motifs (66-QIGYWN-71 and 92-FYYLGTGPH-100) that were found in both TGEV and PEDV N proteins. The later motif is also conserved in other coronaviruses ([@bib0190]) and mediates interspecies antigenic cross-reactivity among coronaviruses, even from different genera ([@bib0625]). Strikingly, only TGEV Miller, but not TGEV Purdue antisera showed one-way antigenic cross-reactivity with PEDV strains. The reasons for these unexpected findings are unknown. However, the antigenic cross-reactivity observed between PEDV and TGEV strains raised concerns about the specificity of PEDV whole virus or N protein-based serologic assays. One recombinant PEDV N protein-based ELISA showed weak cross-reactivity with one TGEV- and one PRCV-infected pig serum sample. Therefore, a more conservative cut-off value had to be used in this assay (Dvorak et al. presented at North American PRRS Symposium. Chicago, IL, USA. 2013. Abstract \#22). However, another PEDV N protein-based ELISA assay showed no cross-reactivity with TGEV (Purdue and Miller) and PRCV antisera ([@bib0405]). We speculate that convalescent TGEV Miller antisera collected from the field and displaying low cross-reactivity with PEDV N proteins might be interpreted as background or non-specific reactions. This could be the reason why the antigenic cross-reaction between TGEV and PEDV strains was reported infrequently. Truncation of the antigenic site in the N-terminal region could help exclude the possible serological cross-reactivity and enhance the sensitivity/specificity of the immunoassays. Alternatively, PEDV membrane (M) and S proteins could serve as specific antigens for immunoassays ([@bib0145], [@bib0155], [@bib0280], [@bib0435]). Because viral neutralizing epitopes are located on the S protein, the results of PEDV S protein-based immunoassays correlated well with viral neutralization (VN) titers ([@bib0435]), which is important for clinical protection. In addition, antibodies against the S protein remained detectable for longer periods of time than antibodies to the N protein in the sera of PEDV-infected pigs ([@bib0280]). However, different antigenicity among S epitopes of the relevant PEDV strains ([@bib0325], [@bib0650]) also raises concerns for the comprehensive detection of diverse PEDV strains.Table 1Antigenic cross-reactions as determined by CCIF among various strains of PEDV and TGEV using hyperimmune or convalescent pig PEDV and TGEV antisera[a](#tblfn0005){ref-type="table-fn"}.Table 1Virus strain[a](#tblfn0005){ref-type="table-fn"}Antiserum to PEDV strain and ID number[a](#tblfn0005){ref-type="table-fn"}PEDV PC22A, highly virulentPEDV S INDEL Iowa106PEDV S 197DEL PC177PEDV CV777, classic[b](#tblfn0010){ref-type="table-fn"}TGEV MillerTGEV PurdueAnti-PEDV PC22A-likePE125 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}**2560**[c](#tblfn0015){ref-type="table-fn"}25602560640\<10\<10PE276 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}**2560**25602560640\<10\<10  Anti-PEDV S INDEL Iowa106PV109 [g](#tblfn0035){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}2560**2560**25602560\<10\<10PV151 [g](#tblfn0035){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}640**640**640640\<10\<10  Anti-PEDV S 197DEL PC177PE312 [d](#tblfn0020){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}640640**640**640\<10\<10PE342 [d](#tblfn0020){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}640160**640**640\<10\<10  Anti-PEDV CV777PC13 [g](#tblfn0035){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}^,^[b](#tblfn0010){ref-type="table-fn"}160160160**640**\<10\<10PC14 [g](#tblfn0035){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}^,^[b](#tblfn0010){ref-type="table-fn"}640640 ^5^640**640 ^e^**\<10\<10  Anti-TGEV MillerS409 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}640640640640**10,240**10,240M20 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}160160160160**10,240**10,240  Anti-TGEV PurdueS411 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}\<10\<10\<10\<102560**10,240**M2 [d](#tblfn0020){ref-type="table-fn"}^,^[e](#tblfn0025){ref-type="table-fn"}\<10\<10\<10\<1010,240**10,240**RR441 [d](#tblfn0020){ref-type="table-fn"}^,^[f](#tblfn0030){ref-type="table-fn"}\<10\<10\<10\<10640**2560**[^1][^2][^3][^4][^5][^6][^7]

On the other hand, none of the VN assays revealed reactivity between TGEV and PEDV strains ([Table 2](#tbl0010){ref-type="table"} ) ([@bib0325], [@bib0445]). Therefore, the inactivated or attenuated vaccines used to control and prevent swine viral diarrhea diseases were designed as bivalent or trivalent (e.g., TGEV, PEDV and porcine rotavirus G5 type) ([@bib0575]) vaccines in countries where both PEDV and TGEV are endemic. In China, two experimental DNA vaccines bearing the full length TGEV and PEDV S genes simultaneously ([@bib0380], [@bib0680]) were designed as well.Table 2PEDV neutralizing antibody titers determined by fluorescent focus virus neutralization assay[a](#tblfn0040){ref-type="table-fn"}.Table 2Antiserum to PEDV strain and ID number[a](#tblfn0040){ref-type="table-fn"}Virus strain[a](#tblfn0040){ref-type="table-fn"}PEDV PC22A, highly virulentPEDV S INDEL Iowa106PEDV S 197DEL PC177PEDV CV777, classic[b](#tblfn0045){ref-type="table-fn"}Anti-PEDV PC22A like-PE125 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}**1024**[c](#tblfn0050){ref-type="table-fn"}1024102464PE276 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}**256**25625664  Anti-PEDV S INDEL Iowa106PV109 [g](#tblfn0070){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}256**256**256256PV151 [g](#tblfn0070){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}16**64**6416  Anti-PEDV S 197DEL PC177PE312 [d](#tblfn0055){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}1616**16**16PE342 [d](#tblfn0055){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}256256**256**256  Anti-PEDV CV777PC13 [g](#tblfn0070){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}^,^[b](#tblfn0045){ref-type="table-fn"}646464**1024**PC14 [g](#tblfn0070){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}^,^[b](#tblfn0045){ref-type="table-fn"}512512512**512**  Anti-TGEV MillerS409 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}\<4\<4\<4\<4M20 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}\<4\<4\<4\<4  Anti-TGEV PurdueS411 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}\<4\<4\<4\<4M2 [d](#tblfn0055){ref-type="table-fn"}^,^[e](#tblfn0060){ref-type="table-fn"}\<4\<4\<4\<4RR441 [d](#tblfn0055){ref-type="table-fn"}^,^[f](#tblfn0065){ref-type="table-fn"}\<4\<4\<4\<4[^8][^9][^10][^11][^12][^13][^14]

3.2. Antigenic relationships among PEDV, TGEV, and porcine deltacoronaviruses {#sec0080}
-----------------------------------------------------------------------------

Porcine deltacoronavirus (PDCoV) is a newly emerged porcine enteropathogenic coronavirus, identified in 2014 ([@bib0370], [@bib0645]). Recombinant full-length PDCoV N ([@bib0555]) or the S1 region of S protein- ([@bib0600]) based ELISA assays have been developed and showed no cross-reactivity with PEDV antisera. However, a whole virus-based ELISA and Western blot showed two-way antigenic cross-reactivities between PEDV VBS2 strain and PDCoV Michigan/8977/2014 strain ([@bib0340]). Sequence analysis of the N proteins showed 4 motifs (47-GYW-49, 68-FYYTGTGPRGNLKY-81, 194-PKG-196, and 329-EWD-331) are conserved between PEDV and PDCoV, probably leading to the cross-reactivities in the immunoassays. Interestingly, no antigenic cross-reactivity between PEDV and PDCoV was detected in either virus-infected cells or intestinal tissues using CCIF or immunohistochemistry (IHC) staining ([@bib0340]). The discrepancy of different assays was suggested to result from different sensitivity among immune assays and/or the exposure of hidden epitopes on viral N proteins by protein denaturing steps in the ELISA and Western blot ([@bib0340]). In our laboratory, two pig hyperimmune TGEV Miller antisera (S409 and M20) and one mouse ascites TGEV N protein MAb (14G9.3C) cross-reacted with PEDV in CCIF assays. However, the same panel of antibodies did not cross-react with PDCoV in our CCIF assays (Lin and Saif, unpublished data). On the other hand, no virus cross-neutralization activity was observed between PEDV and TGEV, or between PEDV and PDCoV ([@bib0325], [@bib0340]). If PDCoV is found to be widespread in swine and a factor in enteric disease, it is possible that PDCoV may be included in future multivalent vaccines against swine enteric viral diseases.

3.3. Antigenic variations among PEDV strains {#sec0085}
--------------------------------------------

### 3.3.1. Antigenic variations between classical and emerging PEDV strains may contribute to the failure of traditional attenuated vaccines in Asia {#sec0090}

Under the pressure of herd immunity, the S genes of coronaviruses mutate frequently and some of the amino acid changes lead to changes in viral antigenicity to aid in virus escape from pre-existing immunity. Thus, periodic updates of vaccines may be required to ensure sufficient efficacy against emerging virus variants. For example, antigenic variations between bovine coronavirus field and vaccine strains were demonstrated by VN assay ([@bib0240]). PEDV has one single serotype as measured by VN assay using convalescent and hyperimmune antisera. However, more evidence based on field observations, viral gene sequence analysis and serologic assays suggested that the emerging highly virulent (non-S INDEL) PEDV strains differed antigenically in various degrees from classical PEDV strains. Detailed VN results are described below.

In Asian countries, many classical PEDV strains, including prototype CV777, Japan 83P-5 and Korea DR13 strains, were attenuated via continuous cell culture passage and licensed as inactivated or attenuated vaccines ([@bib0415], [@bib0490], [@bib0530]). These traditional attenuated PEDV vaccines showed good clinical efficacy against classical PEDV strains, until emerging PEDV outbreaks started at the end of 2010 in China ([@bib0540], [@bib0575], [@bib0565]). To date, the use of classical PEDV strain-based inactivated and attenuated vaccines may still help to reduce the severity of disease. However, many pig herds followed the routine vaccination program, but still experienced high mortality rates among newborn piglets caused by emerging highly virulent PEDV strains ([@bib0220], [@bib0540]). Epidemiological studies have shown that the highly virulent PEDV strains have become pandemic in the swine population ([@bib0085], [@bib0270], [@bib0295], [@bib0520]).

Initially, sequence comparisons of neutralizing epitopes on the S protein ([@bib0305]) suggested that the antigenic variations between classical and emerging non-S INDEL (highly virulent) PEDV strains are the major reason for vaccine failure ([Table 3](#tbl0015){ref-type="table"} ). Several regions on PEDV S protein were recognized as containing the neutralizing epitopes, including a CO-26 K equivalent epitope COE (aa 499--638), SS2 (aa 748--755), SS6 (aa 764--771) and 2C10 (aa 1368--1374) ([@bib0035], [@bib0150], [@bib0235], [@bib0410]). Compared with classical PEDV vaccine strains, several SNPs leading to 8--11 individual amino acid changes located on COE epitope and 1--2 amino acid changes located on SS6 epitope were observed in highly virulent PEDV strains ([@bib0305]). Among them, three (A522S, A554 S and G599S) and one (Y766S) were serine substitutions ([Table 3](#tbl0015){ref-type="table"}) ([@bib0085], [@bib0180], [@bib0205], [@bib0610]). In addition, bioinformatics predicted that the S protein of highly virulent PEDV strains changed in primary/secondary structures, high-specificity *N*-glycosylation sites, potential phosphorylation sites, and palmitoylation sites ([@bib0085], [@bib0180]). These changes may affect viral antigenicity and change viral neutralizing activity.Table 3Analysis of amino acid variations in CO-26K equivalent epitopes (COEs) of the S glycoprotein of PEDV strains. Amino acids that differ from CV777 but are identical to the majority of emerging strains are labeled with black background; amino acids that differ from CV777 and the majority of emerging strains are labeled with gray background.Table 3![](fx1_lrg.gif)[^15][^16]

In addition to molecular evidence, antigenic variations between classical and emerging highly virulent (non-S INDEL) PEDV strains were demonstrated in several serological cross-reactivity assays ([@bib0270], [@bib0325], [@bib0650]). A retrospective study analyzing 27 Korean PEDV strains from 1998 to 2013 showed that the S protein sequences of the field strains exhibited a maximum of 10% difference from the classical attenuated vaccine strains ([@bib0270]). One serum sample collected from a pig immunized with attenuated PEDV vaccine strain SM98 neutralized the homologous strain (SM98) with a titer of 512. The same serum reacted with another PEDV vaccine 83-P5 (P5-V) strain and four field PEDV strains (KDGG10YO, KDGG12HWN, KDGN12DJ and KDGN13_295BG) at lower titers (ranging from 8 to 32) ([@bib0270]). In our laboratory, two-way antigenic cross-reactivities among prototype PEDV CV777 and three genetically distinct US PEDV strains (highly virulent non-S INDEL PEDV PC22A, S INDEL Iowa106, 197-DEL PC177) were tested with a panel of pig antisera ([Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"}) and mouse MAbs to PEDV ([@bib0325]). In agreement with the phylogenetic distance ([@bib0400], [@bib0630]), classical PEDV CV777 strain showed more differences in antigenic cross-reactivity compared with the other US PEDV strains. However, inconsistences in cross-reactivity were evident using antisera from different pigs. One of two hyperimmune PEDV PC22A pig antisera and one of two convalescent PEDV CV777 pig antisera showed 16-fold differences between the homologous and heterologous VN titers ([Table 2](#tbl0010){ref-type="table"}). Subsequently, similar observations were reported for the S protein by [@bib0650]. Mice immunized with the recombinant S proteins of either CV777 strain or emerging highly virulent China LNCT2 strain both generated polyclonal neutralizing antibodies against homologous and heterologous PEDV strains in serum samples. However, the homologous titers were two-fold higher than the heterologous titers in CCIF, ELISA and VN assays. Overall, the above studies showed that pigs or mice immunized with classical attenuated PEDV vaccine strains usually displayed similar or lower serum antibody titers against the emerging highly virulent PEDV strains (2--16 fold differences), suggesting the classical PEDV vaccine strains may only provide partial cross-protection against the highly virulent PEDV strains ([@bib0540]). However, *in vivo* cross-protection studies are needed to confirm the *in vitro* cross-reactivity data.

### 3.3.2. Emerging PEDV strains are predicted to be antigenically variable based on sequence analysis {#sec0095}

Although differences in antigenicity between classical and highly virulent PEDV clusters have been studied, the antigenic variations among PEDV strains within the same phylogenetic cluster are less studied in serological assays. Comparative analysis of TGEV, PRCV, and murine hepatitis virus revealed that the NTD and the C-terminal receptor binding domain (RBD) of the S1 region of the S protein contained two main antigenic sites. [@bib0210] reported that the highly virulent PEDV strains from China had an increased number of substitutions within the S1 domain compared with the highly virulent American strains, probably due to the longer circulation time of PEDV in pigs in China. Compared with the attenuated classical vaccine strain DR13, 29 of 185 (16%) of non-S INDEL NA PEDV strains and 19 of 34 (56%) of emerging Asian strains had at least one amino acid substitution in the RBD. In this review, we compared the neutralizing epitopes from different PEDV strains ([Table 3](#tbl0015){ref-type="table"}). Among the four neutralizing epitopes, two epitopes (SS2 and 2C10) were conserved ([@bib0305]). The neutralizing epitopes of prototype PEDV CV777 strain were the same as those of classical PEDV SM98 vaccine strain, except for one amino acid difference (S764P) in the SS6 epitope. Compared with PEDV CV777 strain, other classical attenuated PEDV strains (83P-5-P100 and attenuated DR13) and classical Asian field strains had 7--8 and 1--2 amino acid differences located in COE and SS6 epitope, respectively. On the other hand, emerging highly virulent PEDV strains had variations mainly in COE (most frequently, in amino acid positions 517, 521, 523 and 605). Compared with the vaccine strain CV777, five highly virulent PEDV strains (JY5C, JY6C, JY7C, YJ3F, and YJ7C) detected in Gansu Province, China had eight mutations (A517S, S523G, V527I, T549S, G594S, A605E, L612F, and I635V) in the neutralizing epitope COE. However, three (JY5C, JY6C and JY7C) of these highly virulent PEDV strains had one additional mutation (L521H) in the neutralizing epitope COE ([Table 3](#tbl0015){ref-type="table"}) ([@bib0610]). Higher sequence diversity was observed in Guangdong Province, China, where ten PEDV strains, including one classical strain GDS03, isolated during 2011--2013, had five different patterns of amino acid sequences in neutralizing epitope COE ([Table 3](#tbl0015){ref-type="table"}) ([@bib0180]). The majority of emerging highly virulent NA PEDV strains had the same amino acid sequences in neutralizing epitopes. Compared with other NA highly virulent PEDV strains, USA/Minnesota79/2013 had one (E605D), USA/Missouri177/2014 had three (E605D, E633D and V635A), USA/Oklahoma32/2013 had one (G523D) and USA/Oklahoma35 had one (H521R) substitutions in COE epitope ([Table 3](#tbl0015){ref-type="table"}). The significance of these amino acid differences in VN epitopes among these highly virulent PEDV strains has not yet been examined by using MAbs in serological assays or by *in vivo* cross-protection studies in pigs. However, it is likely that higher antigenic variations will appear in the future.

In addition, the amino acids in neutralizing epitopes of S INDEL strains were the same as that of the majority of NA highly virulent strains ([Table 3](#tbl0015){ref-type="table"}), suggesting their cross-neutralization ability and confirmed by our previously reported *in vitro* and *in vivo* studies ([@bib0320], [@bib0325]). Recently, serological cross-reactivity and cross-neutralization between S INDEL (USA/IL20697/2014) and non-S INDEL (USA/IN19338/2013) strains were studied by [@bib0065], [@bib0070]. In their IFA study, serum samples collected from pigs inoculated with non-S INDEL PEDV reacted with homologous and S-INDEL (heterologous) PEDV-infected Vero (ATCC CCL-81) cells. However, the homologous titers were higher than heterologous titers. Alternatively, serum samples collected from pigs inoculated with S-INDEL PEDV showed similar homologous and heterologous titers by IFA and VN assays ([@bib0070]). However, *in vivo* cross-protection also can be affected by additional factors, such as cellular immune responses and in suckling pigs by the lactating sow's milk production ([@bib0165], [@bib0320]). Also serum viral neutralizing antibody level may not reflect IgA viral neutralizing antibody level in milk ([@bib0495]). Whether the circulating antibody plays a role in the protection of piglets against PEDV is still questionable ([@bib0455]). Thus, *in vivo* cross-protection may not always be consistent with *in vitro* virus neutralizing antibody levels ([@bib0325]). Detailed in vivo cross-protections between S INDEL and non-S INDEL PEDV strains were reviewed in Section [5.2](#sec0145){ref-type="sec"}.

3.4. Limitations of the PEDV serological cross-reaction assays and potential solutions {#sec0100}
--------------------------------------------------------------------------------------

Continuous monitoring of genetic and antigenic changes in PEDV strains is critical to control epidemic outbreaks and for vaccine development ([@bib0045], [@bib0390]). However, there are limitations in the comprehensive characterization of antigenic variations among PEDV strains, although cross-protection activity is a primary criterion for vaccine strain selection, and immunity is thought to be a major driving force of virus evolution.

First, unlike the viral genomic information accessible from GenBank, it is difficult to collect large numbers of PEDV strains and produce the corresponding highly specific pig antisera for measuring cross-reactive neutralizing antibody titers. Few virus strains are adapted to cell culture, and in the US it is difficult to import foreign isolates for comparison. Antibody specificities can be influenced by the backgrounds of the experimental animals ([@bib0325]). In addition to inferring the antigenicity by sequence data ([@bib0305], [@bib0570]), expression of recombinant proteins in eukaryotic systems and generating antiserum and/or MAbs in laboratory animals could be alternative methods to explore the antigenic variations among PEDV strains ([@bib0650]). However, whether the structure of recombinant proteins reflects the proteins in the intact virus ([@bib0355]), or whether cross-reactive neutralizing antibody profiles defined using antisera from injected small laboratory animals are similar to those observed using post-infection sera obtained from their natural host in the field needs to be confirmed ([@bib0080]).

Secondly, in the field a post-infection/convalescent antiserum contains polyclonal antibodies that may react with the conserved epitopes and may not reveal the antigenic variations among PEDV strains. The antigenic variations among different TGEV strains could be distinguished by MAbs ([@bib0510]), but not by conventional antisera ([@bib0290]). Therefore, production of a comprehensive panel of PEDV neutralizing MAbs and epitope mapping studies will help to more precisely identify the regions contributing to antigenic variation. One MAb 5F7 against the S protein of highly virulent PEDV CHN/LNCT strain did not cross-react with CV777 strain. Further epitope mapping of PEDV strains is ongoing ([@bib0650]).

Third, the data from serologic assays were usually reported as titration values or titers. When large numbers of viral strains and antiserum data were included, the results were difficult to combine and data below the sensitivity threshold of the assay could not be interpreted. Moreover, results from different laboratories may be inconsistent. To resolve these problems, an antigenic cartography (antigenic map) was originally proposed for mapping the antigenic evolution of the influenza virus, in which ordinal multidimensional scaling was applied to position the antigens/antisera in the map ([@bib0515]). Multiple datasets of the serological assays from different laboratories worldwide could be combined for constructing a comprehensive PEDV antigenic cartography by a computational framework approach ([@bib0030], [@bib0515]). Subsequently, a similar approach was also applied for other RNA viruses with high antigenic variation, such as human enteroviruses ([@bib0080]) and noroviruses ([@bib0115]). In our previous study, the results of CCIF and VN assays showed that the antigenic determinants among three US PEDV strains were conserved. The same two-way antigenic cross-reactivity data among three US PEDV and prototype CV777 strains were re-analyzed by antigenic cartography ([Fig. 4](#fig0020){ref-type="fig"} ). In the antigenic map, the S INDEL Iowa106 strain and the S 197aa-del PC177 strain were located between the highly virulent PEDV PC22A and the classical CV777 strain, showing a well correlation between the phylogenetic distance and antigenic differences. This map will be expanded further when more data becomes available in the future.Fig. 4Antigenic map generated using cross-reactive PEDV and TGEV CCIF serum antibody titers presented in [Table 1](#tbl0005){ref-type="table"}. The relative position of strains, including the prototype PEDV CV777 (black diamond), highly virulent PEDV PC22A (red triangle), S INDEL PEDV Iowa106 (orange hexagon), S 197del PEDV PC177 (green trapezoid), TGEV Miller (purple circle) and TGEV Purdue (blue circle) was adjusted such that the distances between strains in the map represent the corresponding ratios between homologous and heterologous antibody titers. The original data ([Table 1](#tbl0005){ref-type="table"}) was published in our previous study ([@bib0315]). This antigenic map was constructed using webserver (<http://sysbio.cvm.msstate.edu/AntigenMap>) established by [@bib0030].Fig. 4

4. Pathogenicity of PEDV strains {#sec0105}
================================

4.1. Classical PEDV infections cause acute gastroenteritis and intestinal lesions, similar to virulent TGEV infections {#sec0110}
----------------------------------------------------------------------------------------------------------------------

The infection and pathogenic features of classical PEDV CV777 strain were examined in earlier studies ([Table 4](#tbl0020){ref-type="table"} ) ([@bib0100], [@bib0110], [@bib0120], [@bib0140], [@bib0460]). One to twenty day-old cesarean-derived, colostrum-deprived (CDCD) and conventional piglets inoculated with PEDV CV777 had clinical signs between 23 and 40 h post-inoculation (HPI) ([@bib0100], [@bib0120]). About one day after onset of diarrhea, marked villus shortening along with the villus height (VH) versus crypt depth (CD) ratios (VH:CD) reduced from 7 to 8 in the healthy controls to approximately 2--3 for infected pigs were observed ([@bib0120]). Starting from 60 HPI, villous regeneration was observed in CV777-inoculated piglets. These regenerating cells were re-infected by PEDV CV777, resulting in a second peak of infection ([@bib0110]). Earlier research compared the pathogenesis of PEDV CV777 with endemic TGEV Miller strain ([@bib0110], [@bib0460]). PEDV CV777 infection showed more extensive vertical and longitudinal distribution in the digestive tract: both small intestinal and colonic epithelial cells and occasionally, epithelial cells at the base of a villus and the crypt cells could be infected by PEDV CV777. In addition, the progression of PEDV CV777 infection was slower than that in TGEV ([@bib0110], [@bib0465]).Table 4Summary of PEDV pathology studies[a](#tblfn0075){ref-type="table-fn"}.Table 4Age atOnset ofInfection SiteInoculuminoculationVilli atrophyclinicalVertical (location)Longitudinal (extent)PEDV straintype/dosePig type(day-old)(VH:CD ratio)signsVillousCryptD, J, ICReference(Classical strains)CV777Fecal suspension\
(5--7 log PID)CDCD/conventional1--20Moderate to severe (∼2)24--40+++ (entire)NRD (NR), J, I (cont)+[@bib0120]CV777Fecal suspension\
(4 log PID)CDCD2--3Moderate to severe (NR)22--36+++\
(entire)+D, J, I (cont)+[@bib0100]CV777Fecal suspension\
(4 log PID)CDCD2--3Moderate to severe\
(1.5−4.2)22--36NRNRNRNR[@bib0100]Japan/1993(naturally infection)conventional--Severe\
1.1--2.6--+++ (entire)+D, J, I (cont)+[@bib0560]Korea\
SNUVR971496Cell culture (P3)\
(6.5 log TCID~50~)colostrum-deprived1Severe\
(1.1--3.3)12--36+++\
(entire)--D, J, I (cont.)--[@bib0255]  (Highly virulent strains)US PC21AFecal suspension\
(6.3--9.0 log GE)gnotobiotic10--35Severe\
(\<2)25--46+++\
(entire)NRD, J, I (cont.)+[@bib0225]US PC21AFecal suspension\
(11.8 log GE)conventional9Severe\
(1.1--1.4)∼24+++\
(entire)NRD, I, J\
(cont)+[@bib0230]US PC21AFecal suspension\
(10 log GE)conventional4Severe\
(0.9--2.0)\<24+++\
(entire)+D, J, I\
(cont)+[@bib0320], [@bib0325]US PC21AFecal suspension\
(11.8 log GE)conventional26Moderate to severe\
(1.2--3.0)72--182++\
(entire)NRD, I, J\
(cont)+[@bib0230]US PC22ACell culture (P3)\
(1--4 log PFU)CDCD/conventional3--4Severe\
(0.8--2.3)18--24+++\
(entire)+D, I, J\
(cont)+[@bib0335]USA/IN19338/2013Cell culture (P7)\
(3.7-0.3 log TCID~50~)conventional5Severe\
(1.2--1.7)24+++\
(entire)NRD, J (NR), I (cont)NR[@bib0605]US/Iowa/18984/2013Cell culture (P6)\
(3 log PFU)conventional21Moderate to severe\
(1.8--4.2)48--120+++\
(entire)NRD, J, I\
(cont)NR[@bib0345]US/Iowa/18984/2013Cell culture (P6)\
(3 log PFU)CDCD5 hSevere\
(1.9--3.0)24+++\
(entire)NRD, J, I (cont)NR[@bib0350]Japan ZK-CHRCell culture\
(1.6 log TCID~50~)SPF7NR24NRNRNRNR[@bib0665]  (S-INDEL strains)Japan ZK-OCell culture\
(1.1 log TCID~50~)SPF7NRNDNRNRNRNR[@bib0665]US Iowa106Fecal suspension\
(10--12 log GE)conventional4Moderate to severe\
(1.4--5.4)24--72++\
(entire)--D (patch), J, I (cont)--[@bib0320], [@bib0325]US/IL20697/2014Cell culture\
(4 log TCID~50~)Conventional/milk replacer5MildMinimal+/++NRD, J (NR),\
I (patch)+[@bib0065], [@bib0070][^17][^18]

However, not all of the pathological features of prototype PEDV CV777 infection were consistently observed for other PEDV strains ([Table 4](#tbl0020){ref-type="table"}). The infection of one-day-old, colostrum-deprived piglets with Korea classical PEDV strain (SNUVR971496) induced severe villous atrophy with the lowest mean VH:CD ratio (1.11 ± 0.34) at 60 HPI. However, in these very young piglets, no PEDV antigens or nucleic acids were detected in epithelial cells lining the crypts, and positive-staining cells were lacking in the colon by IHC staining ([@bib0260]) and *in situ* hybridization ([@bib0255]). Similarly, different levels of virulence among TGEV strains were also reported ([@bib0250]). Therefore, the pathogenicity of TGEV/PEDV infection in pigs depended on the viral strains, the age of pig, how piglets were derived (CD) or if naturally farrowed, the colostrum/milk status (CD) and environment variations ([Table 4](#tbl0020){ref-type="table"}). In general, the clinical signs of PEDV and TGEV infections are indistinguishable in the field.

4.2. Emerging non-S INDEL PEDV strains are highly virulent in pigs {#sec0115}
------------------------------------------------------------------

Based on epidemiologic and clinical observations in the field, the emerging non-S INDEL PEDV strains since 2010 are highly pathogenic and referred to as "highly virulent" PEDV strains. Experimental infection of highly virulent PEDV strains in gnotobiotic ([@bib0225]), CDCD ([@bib0335], [@bib0350]) and conventional ([@bib0320], [@bib0345]) pigs resulted in consistent outcomes and conclusions ([Table 4](#tbl0020){ref-type="table"}).

First, the highly virulent PEDV is very infectious. Approximately one plaque-forming unit (PFU) of the highly virulent PEDV PC22A strain (at passage level 3) caused watery diarrhea in 40% of 4-day-old CDCD piglets within 24 HPI ([@bib0335]). Similarly, the minimal infectious dose of another highly virulent US PEDV strain USA/IN19338/2013 was titrated as 0.056-0.56 TCID~50~ in 5-day-old conventional piglets and 56 TCID~50~ in 21-day-old conventional weaned pigs, respectively ([@bib0605]).

Secondly, the disease is lethal and the infection progresses rapidly in nursing piglets. Very low inoculation doses induced clinical signs within 24 HPI and deaths within 96 HPI ([@bib0335], [@bib0350], [@bib0605]).

Thirdly, the highly virulent PEDV infections occur throughout the intestine. In addition to jejunum and ileum, the duodenum and cecum/colon were also susceptible to PEDV infection ([@bib0225], [@bib0320], [@bib0350]). PEDV antigens were mainly detected in the cytoplasm of intestinal epithelial cells located both on the tip and lateral walls of villi and in the villus/crypt border ([@bib0225]). Occasionally, individual or clustered crypt epithelial cells were infected ([@bib0320], [@bib0335], [@bib0550]). Whether the regenerative capacity of the crypts is affected by PEDV infection is still unknown. In our laboratory, two markers for crypt proliferation (Ki67) and stem cells (LGR5) were studied. Compared with mock-inoculated conventional piglets, the number of LGR5-positive cells and proliferation of intestinal crypts of 10-14-day-old conventional piglets increased remarkably at 3--5 DPI of PEDV PC21A, reflecting a compensation for villous atrophy by crypt regeneration ([@bib0230]).

Fourth, the highly virulent PEDV strain induced severe villous atrophy. In the majority of CDCD and conventional suckling piglets infected with highly virulent PEDV PC21A or PC22A strain, the VH:CD ratios were \<2 and even \<1 in some cases ([@bib0320], [@bib0335]). Moreover, the highly virulent PEDV not only severely damaged the infected enterocytes but also rapidly spread to infect the regenerated enterocytes ([@bib0320]). If piglets did not die immediately during the acute stage of infection, they continued to show moderate to severe degrees of villous atrophy during 5--8 DPI. Continuous monitoring of fecal viral RNA shedding showed that the titers were decreasing consistently, after the first peak of fecal viral shedding. This data indicates that limited numbers of enterocytes were still available to sustain PEDV replication, but to lower levels during the prolonged infection ([@bib0320]).

Fifth, pigs of all ages can be infected by the highly virulent PEDV, but pigs develop age-dependent resistant to PEDV disease ([@bib0015], [@bib0230], [@bib0345]). Experimental inoculation of 2- and 7-day-old CDCD piglets by a Japanese PEDV strain isolated in 1999 resulted in 100% morbidity and mortality. However, only mild diarrhea occurred in 2- and 4-week-old pigs and no clinical signs were observed in 8- and 12-week old pigs ([@bib0500]). In our studies, morbidity was consistently 100% in the PC21A or PC22A-inoculated piglets and their contact-exposed sows ([@bib0320], [@bib0335]). In our laboratories, a slower turnover rate of enterocytes ([@bib0230]) and impaired lytic activity and IFN-gamma production by natural killer cells ([@bib0015]) in 9-day-old nursing piglets being less than in 26-day-old were proposed as explanations for one of the mechanisms of age-dependent resistance to PEDV. However, the highly virulent PEDV strains caused severe growth retardation in weaned pigs and significant impairment in productivity, such as lower farrowing rates, lower total pigs and pigs born alive per litter and decreased nursing performance of sows ([@bib0160], [@bib0330]), leading to the overall negative economic impacts on the pork industry.

Overall, the virulence of highly virulent PEDV was characterized by disease/infection induced by a low infectious dose, short incubation times, severe clinical signs and intestinal lesions, and extensive PEDV replication throughout the intestine ([Table 4](#tbl0020){ref-type="table"}). In addition to antigenic variation, these disease characteristics also explained why current highly virulent PED outbreaks were so devastating in the major pig producing countries in Asia ([@bib0095], [@bib0400], [@bib0565]) and North America ([@bib0550], [@bib0630]).

4.3. INDEL PEDV strains showed lower virulence than the emerging non-S INDEL PEDV strains, but still can induce severe disease in some circumstances {#sec0120}
----------------------------------------------------------------------------------------------------------------------------------------------------

The first US PEDV S INDEL strain, OH851, was isolated from conventional pigs without significant clinical signs ([@bib0645]). Soon thereafter, comparisons of the pathogenicity between S INDEL and highly virulent PEDV strains were conducted in three independent laboratories ([Table 4](#tbl0020){ref-type="table"}). In Japan, one-week-old, specific pathogen-free (SPF) piglets inoculated with S INDEL PEDV ZK-O strain had delayed onset of PEDV fecal RNA shedding, lower fecal diarrhea scores and fecal viral RNA titers compared with the highly virulent PEDV ZK-CHR stain, suggesting S INDEL strains may be less pathogenic ([@bib0665]). In our laboratory, all the conventional nursing piglets inoculated with the field S INDEL PEDV Iowa106 strain at 4 days of age developed diarrhea. However, the virulence of S INDEL PEDV Iowa106 was lower than that of the highly virulent PEDV strains as evident by: (1) a longer incubation time (delayed onset of clinical signs and the peak of viral RNA shedding); (2) a shorter duration of diarrhea; (3) relatively higher VH:CD ratios; (4) a lower percentage of PEDV positive enterocytes; (5) more limited intestinal regions of virus infection (crypt not involved); and (6) overall lower piglet mortality (18%) compared with the highly virulent PC21A strain (55%) ([@bib0320]). In comparison, [@bib0065], [@bib0070] infected conventional farrowed, 5-day-old non-suckling (fed with milk replacer and yogurt) piglets with a TC US S INDEL PEDV strain (IL20697/2014) and three other US highly virulent PEDV strains (IN19338/2013, NC35140/2013, and NC49469/2013). The S INDEL PEDV strain (IL20697/2014) caused no or minimal clinical signs, lower reductions in body weight gain, more limited gross and microscopic lesions and lower fecal viral shedding and tissue PEDV antigen scores ([@bib0065]). However, individual and litter variations, as commonly observed in the field ([@bib0545]), were reported only in our piglet studies: the mortality of S INDEL Iowa106-inoculated piglets was 0% in three litters, but 75% in the fourth litter ([@bib0320]). In addition, the sows contact-exposed to their infected piglets became infected by S INDEL Iowa106 and two of four sows showed anorexia and diarrhea. Outbreaks of European S INDEL PEDV strains in southern Germany ([@bib0545]) and southern Portugal ([@bib0385]) still caused high mortality (approximately 70%) in suckling piglets. Therefore, although the consensus was that the S INDEL strains were of lower virulence ([@bib0320], [@bib0325], [@bib0645], [@bib0665]), they still induced severe disease in some circumstances, such as if the sow became infected and ill. If sows had decreased appetite and milk production, the lactogenic immunity could be disrupted or decreased ([@bib0045]) and their suckling piglets were likely to die ([@bib0320], [@bib0385], [@bib0545]). Also piglets with lower birth weight might compete less efficiently for milk and receive less nutrition and lower lactogenic immunity than their littermates. The severity of clinical signs caused by S INDEL PEDV infection showed a negative correlation with the birth body weight of piglets ([@bib0320]).

4.4. TC PEDV strains at high passage levels showed reduced virulence similar to attenuated TGEV strains {#sec0125}
-------------------------------------------------------------------------------------------------------

Highly virulent TGEV strains, such as US Miller at low cell culture passage level 3 (passage 3), is associated with short incubation time, extensive spread of infection throughout the small intestine, infection in higher portions of small intestinal enterocytes and marked damage to the villous epithelium. On the other hand, strains of TGEV attenuated by 115 or 350 passages in cell culture (P115 and B1-350) produced scattered foci of infection in villous enterocytes only in the jejunum and ileum ([@bib0465], [@bib0480]). In addition, the P115 virus was found to replicate to higher titers in the upper respiratory tract (nasal shedding) than in the gut (fecal shedding) ([@bib0620]). Similarly, continued passages of TC PEDV also generated attenuated variant strains which caused milder or no diarrhea in pigs ([@bib0060], [@bib0490], [@bib0530], [@bib0525]). The same properties of infection, including milder/no clinical signs and intestinal lesions and lower tissue antigen scores, were still relevant indicators for attenuation when the high passaged PEDV strains were compared with the parent virulent strains ([@bib0060]).

4.5. Several PEDV variants with various deletions in S gene showed reduced virulence {#sec0130}
------------------------------------------------------------------------------------

For the TGEV, a large (224 aa)-deletion in the NTD of S1 region of S protein reduced its virulence and changed its tissue tropism from intestinal to respiratory \[subsequently designated porcine respiratory coronavirus (PRCV)\] ([@bib0450], [@bib0465], [@bib0480]). A mutant PEDV strain PC177 has a 197 amino acid (aa)-deletion in the S1 NTD also was attenuated in pigs. Compared with the highly virulent PEDV PC22A, 4-day-old, CDCD piglets inoculated with 1000 TCID~50~ of PEDV PC177 showed milder diarrhea, lower fecal PEDV RNA shedding titers, milder villous atrophy and lower intestinal tissue antigen scores. Mortality rates were 0% and 100% in the PC177- and PC22A-inoculated piglets, respectively (Hou et al., the 35th Annual Meeting of American Society of Virology, Blacksburg, VA, June 18--22, 2016). Unlike TGEV and PRCV, however, the results of our IHC staining did not suggest changes in tissue tropism of the PC177 strain. In a recent report, no mortality occurred in 7-day-old suckling field piglets (n = 120) infected with a Japanese PEDV strain (Tottori2/2014) with a 194 aa-deletion (aa Δ23-216) in the S1 NTD, similar to that of PC177 (aa Δ34-230) ([@bib0395]). Both findings suggest that the large deletion in the S1 NTD may be responsible for the reduced virulence. In addition, a variant Chinese PEDV field strain (FL2013) was isolated from a sow with mild clinical signs and with reduced virulence in her 3-day-old neonatal piglets ([@bib0675]). The backbone of the FL2013 genome was identical to other highly virulent PEDV strains ([Fig. 1](#fig0005){ref-type="fig"}). However, the extreme C-terminus of the FL2013S gene has a unique 21 nt-deletion, leading to a 7 aa- deletion (FEKVHVQ) in comparison with other highly virulent PEDV sequences ([@bib0675]). The same 7 aa-deletion is also observed in the classical PEDV CHN/LZC/before 2006 strain. Whether these large deletions or early termination of S protein alone alter viral infectivity, pathogenicity and replication efficiency can be further examined by reverse genetics technology ([@bib0020], [@bib0215]).

5. Considerations for vaccine strain selection: PEDV virulence attenuation and in vivo cross-protection between PEDV strains {#sec0135}
============================================================================================================================

The highly virulent PEDV strains spread rapidly and caused very high mortality in suckling piglets. Failure of the live attenuated classical PEDV vaccines in Asia ([@bib0540], [@bib0575]) and the lack of live attenuated PEDV oral vaccines in North America ([@bib0220]) necessitates the development of future PEDV vaccines for swine based on the emerging strains. Because PEDV causes up to 100% mortality in neonatal pigs (\<7-day-old), the aim of vaccination for PEDV is to immunize the sows to induce adequate maternal immunity to passively protect neonatal piglets from PED ([@bib0045], [@bib0480]). This objective may be accomplished by the selection of the optimal viral strain, whose antigenicity is close to that of the epidemic strain, but of minimal pathogenicity in young piglets, as well as the optimal vaccine approach.

5.1. Concerns about the use of autogenous PEDV strains for feedback or for inactivated vaccines to induce protection in pigs {#sec0140}
----------------------------------------------------------------------------------------------------------------------------

Before effective PEDV vaccines became available in the US and many Asian countries, intentional infection of sows with an autogenous PEDV strain during gestation, feedback exposure was used to induce lactogenic immunity for piglets ([@bib0045], [@bib0220], [@bib0540]). When the neonatal piglets were protected by sufficient amounts of lactogenic antibodies, experimental piglet inoculation with doses ∼100 and 1000 PFU of PEDV did not induce major clinical signs or microscopic lesions ([@bib0335]). Feedback methods utilizing PEDV infected material from the same outbreak farms bypassed the issues regarding antigenic variations between the classical and emerging PEDV strains and had variable success in preventing reinfection. However, the safety of using this strategy as a disease control method was questionable ([@bib0045]). Alternately, inactivated vaccines have advantages of vaccine safety, but usually elicit less robust and lower protective neutralizing/lactogenic immune responses than modified live vaccines. To date, detailed efficacy studies of the PEDV inactivated (Zoetis, Florham Park, NJ) or alphavirus vectored (Harrisvaccines, Ames, IA) vaccines conditionally licensed in the US are lacking.

5.2. INDEL PEDV infections induced insufficient cross-protection in pigs against the highly virulent PEDV strains {#sec0145}
-----------------------------------------------------------------------------------------------------------------

Whether the US PEDV S INDEL strains could be used as an effective live vaccine to cross-protect piglets from highly virulent PEDV strains has been investigated in several studies. Compared with prototype PEDV CV777, PEDV S INDEL Iowa106 is antigenically closer to the highly virulent PEDV PC22A in the S protein-based phylogenetic tree ([Fig. 3](#fig0015){ref-type="fig"}) and antigenic map ([Fig. 4](#fig0020){ref-type="fig"}). We reported that convalescent antisera obtained from S INDEL-infected pigs cross-reacts with the highly virulent PEDV PC22A strain in two-way CCIF and VN assays ([Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"}, [Fig. 4](#fig0020){ref-type="fig"}) ([@bib0325]). However, these *in vitro* immunological assays only examined the IgG antibodies in serum and may not reflect lactogenic antibodies *in vivo* challenge conditions. Because PEDV infects and replicates in the intestinal mucosa, development of mucosal immunity that relies on the quality and quantity of antibodies present in the intestinal mucosa or colostrum/milk, is critical for optimal active protection ([@bib0045], [@bib0475]). In the study of [@bib0165] with 10 conventional sows, either with no previous PEDV infection or recovered from natural infection by an S INDEL PEDV at 7 months prior to farrowing, were orally boosted with a highly virulent PEDV strain at 109 day of gestation. Subsequently, the piglets were challenged at 3 days of age with a highly virulent PEDV strain. The S INDEL PEDV pre-exposed sows provided higher lactogenic immunity compared with unexposed sows. However, the PEDV-challenged, passively immunized suckling piglets showed extreme litter variations with morbidity rates ranging from 0% to 100%, although their mothers were naturally pre-exposed to an S INDEL PEDV strains and re-boosted with the virulent PEDV strain ([@bib0165]). In our studies, we focused on active immunity to S INDEL PEDV in conventional suckling piglets born to PEDV-naïve sows. The piglets inoculated with S INDEL PEDV Iowa106 strain at 4-days of age and challenged with highly virulent PEDV PC21A at 24-32-days of age. Most piglets (81%, 13/16) recovered from S INDELIowa106 infection still had diarrhea after challenge with PC21A strain, while no piglets (0%, 0/4) recovered from the highly virulent PEDV PC21A infection developed disease after challenge with the homologous strain ([@bib0320]). Therefore, we concluded that the S INDEL PEDV strain provided only partial active cross-protection to the piglets from a subsequent challenge with a highly virulent PEDV strain.

5.3. Attenuated TC PEDV strains at high passage levels can be considered as vaccine candidates {#sec0150}
----------------------------------------------------------------------------------------------

Attenuated PEDV generated via serial cell culture passages, as well as the naturally occurring mild S INDEL PEDV strains, may serve as live attenuated vaccine candidates ([@bib0060], [@bib0490]). High cell culture passage level of PEDV strains could facilitate the generation of viruses that replicate well in cell culture, but less efficiently in the natural host, leading to viral attenuation. High titers of virus stocks that are free of other pathogens and can be generated and used to develop cost-effective inactivated and/or live attenuated vaccines. Many live attenuated classical PEDV strain vaccines had been used in Asian countries for decades ([@bib0575], [@bib0580]). They showed no disease in sows and piglets, but still induced robust immune responses in sows ([@bib0530]). More recently, attenuated vaccine candidates have been produced via continuous cell culture passage of US PEDV PC22A strain in our laboratory (Lin et al. presented at Conference of Research Workers in Animal Diseases, December 6--8, 2015, Chicago, USA. Abstract no. 177) and Chinese PEDV YN strains in Dr. He's laboratory ([@bib0060]). A highly virulent PEDV YN strain was serially propagated in Vero-C1008 cells for 200 passages. At passage 144, the virus caused no clinical signs or histopathologic lesions in 10-day-old piglets. Compared with its parent strain (YN-P1), YN-P144 had 3 amino acid deletions and 13 amino acid substitutions in the S protein, 8 aa-early termination of ORF3 protein and other amino acid changes (9, 2, 2 and 2 in ORF1ab, E, M and N regions). However, none of the changes occurred in neutralizing epitopes. Although detailed data regarding the serological cross-reactivity has not been reported, the S proteins of YN-P1 and YN-P144 had a high (99.13%) sequence identity.In the same study, PEDV YN-P144 was tested safe for pregnant sows and newborn piglets, and induced immunity in sows and their piglets against a highly virulent PEDV challenge. In our laboratory, one US original highly virulent PEDV strain, PC22A, was continuously passaged in Vero cell lineages as described ([@bib0400]). After passage 100, it showed reduced virulence in 4-day-old CDCD piglets (Lin and Wang, unpublished data). However, concerns remain that the attenuated PEDV strains may recover their virulence via mutation in the natural hosts or generate new virulent strains by exchanging their genes with field strains by recombination (See Section [2](#sec0010){ref-type="sec"} for examples of PEDV recombination) unless the viral genes responsible for recombination are defective, or suicide strains are engineered (limited replication competency).

5.4. Reverse genetics technology is a useful tool to study the molecular attenuation mechanisms of PEDV and to generate attenuated PEDV vaccines {#sec0155}
------------------------------------------------------------------------------------------------------------------------------------------------

The use of reverse genetics technology to generate PEDV infectious clones will allow targeted mutations in virulence genes and the engineering of genomic changes that limit PEDV recombination *in vivo* ([@bib0020], [@bib0215]). Truncation of ORF3 protein observed in attenuated PEDV CV777 ([@bib0640]) and ORF3 gene mutations in attenuated DR13 ([@bib0525]) suggested that ORF3 could be a region other than the S gene associated with viral virulence in vivo. Previous studies indicated that PEDV ORF3 encodes an ion channel protein and regulates virus production ([@bib0640]). However, truncation of ORF3 also occurred in low-passaged (P15) YN strain suggesting that it may be related to cell culture adaption, and not necessarily to viral attenuation ([@bib0060]). In our recent study, PEDV PC22A ORF3 gene was replaced by a red fluorescent protein gene using revere genetics technology ([@bib0020]). This ORF3-deleted PEDV infectious clone showed slightly reduced virulence in gnotobiotic piglets. Deletion of PEDV ORF3 did not change viral antigenicity, but alone it was not sufficient for complete virulence attenuation. With the accumulation of knowledge regarding the molecular mechanisms of PEDV attenuation, reverse genetics will help to rationally design PEDV vaccine candidates in the future.

6. Conclusions {#sec0160}
==============

Since the emergence of PEDV in England in 1971, different PEDV strains with various genetic, antigenic and pathologic properties have been detected in pigs. PEDV mutates constantly and recombination occurs frequently among PEDV strains and sometimes between PEDV and other coronaviruses. Currently, emerging non-S INDEL PEDV strains are highly virulent and cause severe threats to swine populations. Antigenic variations among classical, emerging non-S INDEL and S-INDEL PEDV strains were observed. Partial cross-protection between emerging S-INDEL and non-S INDEL PEDV strains and between classical and emerging PEDV strains may exist. The failure of the classical PEDV vaccines in Asia and lack of attenuated vaccines based on the emerging PEDV strains necessitates the development of new PEDV vaccines against the highly virulent strains. Naturally occurring mild PEDV strains, TC PEDV strains, and the infectious clone-derived attenuated strains can be considered as live attenuated PEDV vaccine candidates. Continued monitoring and characterization of global PEDV strains is important for precise classification of these viruses and for the development of strategies to prevent and control PED.
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==============================
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[^1]: Negative gnotobiotic (Gn) pig sera (PE71 and HC10078) and mock-inoculated Vero and swine testis (ST) cells were used as negative controls. Data were expressed as the median of sample titrated in triplicates using 4-fold serial dilutions. Detailed materials, methods and data analysis were published in Lin et al. (2015), Journal of Virology 89:3332-3342.

[^2]: Virus strain and antisera were provided by Dr. Hans Nauwynck (Faculty of Veterinary Medicine, Ghent University, Belgium).

[^3]: Boldface values represent homologous titers for each PEDV or TGEV strain.

[^4]: Pig antiserum obtained from gnotobiotic pigs.

[^5]: Hyperimmune antiserum.

[^6]: Convalescent antiserum.

[^7]: Pig antiserum obtained from conventional pigs.

[^8]: Negative gnotobiotic (Gn) pig sera (PE71 and HC10078) and mock-inoculated Vero and swine testis (ST) cells were used as negative controls. Data were expressed as the median of sample titrated in triplicates using 4-fold serial dilutions. Detailed materials, methods and data analysis were published in Lin et al. (2015), Journal of Virology 89:3332-3342.

[^9]: Virus strain and antisera were provided by Dr. Hans Nauwynck (Faculty of Veterinary Medicine, Ghent University, Belgium).

[^10]: Boldface values represent homologous titers for each PEDV or TGEV strain.

[^11]: Pig antiserum obtained from gnotobiotic pig.

[^12]: Hyperimmune antiserum.

[^13]: Convalescent antiserum.

[^14]: Pig antiserum obtained from conventional pig.

[^15]: ^a^PEDV strains in Gansu province, China ([@bib0610]).

[^16]: ^b^PEDV strains isolated during 2011--2013 in Guangdong province, China ([@bib0180]).

[^17]: PID: pig infective dose; TCID~50~: 50% tissue culture infectious dose; PFU: plaque formation unit; GE: genomic equivalent; CDCD: caesarian derived, colostrum deprived; SPF: specific pathogen free; VH: CD: villous height: crypt depth; D-duodenum, J-jejunum, I-ileum; cont. = continuous, NR = not reported; −, +, ++, and +++ denotes none, less than 30%, 30--60% and more than 60% of villous enterocytes showing a PEDV antigen positive signal, respectively.

[^18]: This table is adapted/updated from [@bib0465] "Comparative aspects of enteric viral infections" In: Saif, L.J., Theil, K.W. (Eds.) Viral Diarrhea of Man and Animals. CRC, Boca Raton, Florida, 9--34.
